Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus
Joint Authors
Rahbani, Abdallah
Adwane, Grace
Jomaa, Najo
Source
Case Reports in Neurological Medicine
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-3, 3 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-04-09
Country of Publication
Egypt
No. of Pages
3
Main Subjects
Abstract EN
A 72-year-old man presented with a super-refractory partial status epilepticus following evacuation of a right subdural hematoma.
He failed to respond to treatment with high doses of intravenous valproic acid, Levetiracetam, Lacosamide, Thiopental, and Midazolam.
He was given 4 mg of Perampanel orally via nasogastric tube and the dose was rapidly increased to 8 mg after 12 hours with cessation of clinical and electrical seizures.
Other antiepileptic drugs were tapered progressively with an excellent clinical outcome.
American Psychological Association (APA)
Rahbani, Abdallah& Adwane, Grace& Jomaa, Najo. 2019. Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus. Case Reports in Neurological Medicine،Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1141389
Modern Language Association (MLA)
Rahbani, Abdallah…[et al.]. Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus. Case Reports in Neurological Medicine No. 2019 (2019), pp.1-3.
https://search.emarefa.net/detail/BIM-1141389
American Medical Association (AMA)
Rahbani, Abdallah& Adwane, Grace& Jomaa, Najo. Oral Perampanel for the Treatment of Super-Refractory Status Epilepticus. Case Reports in Neurological Medicine. 2019. Vol. 2019, no. 2019, pp.1-3.
https://search.emarefa.net/detail/BIM-1141389
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1141389
